A First In Human Study Of PF-00184562 In Healthy Volunteers
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are:
- To determine the safety, tolerability and pharmacokinetics of single doses of
PF-00184562; and
- To explore the exposure-response relationship of neuropsychometric and tolerability
measures of PF-00184562 compared to olanzapine.